Centessa Pharmaceuticals (CNTA) Leases: 2023-2025
Historic Leases for Centessa Pharmaceuticals (CNTA) over the last 3 years, with Sep 2025 value amounting to $10.3 million.
- Centessa Pharmaceuticals' Leases fell 8.44% to $10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.3 million, marking a year-over-year decrease of 8.44%. This contributed to the annual value of $11.0 million for FY2024, which is 7.56% down from last year.
- Per Centessa Pharmaceuticals' latest filing, its Leases stood at $10.3 million for Q3 2025, which was down 2.32% from $10.5 million recorded in Q2 2025.
- In the past 5 years, Centessa Pharmaceuticals' Leases ranged from a high of $12.3 million in Q2 2023 and a low of $10.3 million during Q3 2025.
- In the last 3 years, Centessa Pharmaceuticals' Leases had a median value of $11.5 million in 2024 and averaged $11.4 million.
- Data for Centessa Pharmaceuticals' Leases shows a maximum YoY dropped of 8.44% (in 2025) over the last 5 years.
- Quarterly analysis of 3 years shows Centessa Pharmaceuticals' Leases stood at $11.9 million in 2023, then declined by 7.56% to $11.0 million in 2024, then decreased by 8.44% to $10.3 million in 2025.
- Its last three reported values are $10.3 million in Q3 2025, $10.5 million for Q2 2025, and $10.8 million during Q1 2025.